These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1192 related articles for article (PubMed ID: 16207258)

  • 1. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.
    Seed CR; Kiely P; Keller AJ
    Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
    Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
    Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.
    Chiavetta JA; Escobar M; Newman A; He Y; Driezen P; Deeks S; Hone DE; O'Brien SF; Sher G
    CMAJ; 2003 Oct; 169(8):767-73. PubMed ID: 14557314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004.
    Shang G; Seed CR; Wang F; Nie D; Farrugia A
    Transfusion; 2007 Mar; 47(3):529-39. PubMed ID: 17319836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
    O'Brien SF; Yi QL; Fan W; Scalia V; Kleinman SH; Vamvakas EC
    Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study.
    Schreiber GB; Busch MP; Kleinman SH; Korelitz JJ
    N Engl J Med; 1996 Jun; 334(26):1685-90. PubMed ID: 8637512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
    Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
    Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B
    Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia.
    El-Hazmi MM
    Saudi Med J; 2004 Jan; 25(1):26-33. PubMed ID: 14758374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States.
    Zou S; Dodd RY; Stramer SL; Strong DM;
    N Engl J Med; 2004 Aug; 351(8):751-9. PubMed ID: 15317888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates.
    Kane A; Lloyd J; Zaffran M; Simonsen L; Kane M
    Bull World Health Organ; 1999; 77(10):801-7. PubMed ID: 10593027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major risk of blood transfusion in hemolytic anemia patients.
    Omar N; Salama K; Adolf S; El-Saeed GS; Abdel Ghaffar N; Ezzat N
    Blood Coagul Fibrinolysis; 2011 Jun; 22(4):280-4. PubMed ID: 21508832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus type 1 and other viral co-infections among young heterosexual men and women in Argentina.
    de los Angeles Pando M; Biglione MM; Toscano MF; Rey JA; Russell KL; Negrete M; Gianni S; Martinez-Peralta L; Salomon H; Sosa-Estani S; Montano SM; Olson JG; Sanchez JL; Carr JK; Avila MM
    Am J Trop Med Hyg; 2004 Aug; 71(2):153-9. PubMed ID: 15306703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual risk of HIV, HVB and HCV transmission by blood transfusion between 2002 and 2004 at the Abidjan National Blood Transfusion Center.
    Ouattara H; Siransy-Bogui L; Fretz C; Diane KM; Konate S; Koidio A; Minga KA; Hyda J; Koffi-Abe N; Offoumou AM; Abissey S
    Transfus Clin Biol; 2006 Oct; 13(4):242-5. PubMed ID: 16822686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of HIV, HBV, HCV, and HTLV among Pregnant Women in Southwestern Nigeria.
    Opaleye OO; Igboama MC; Ojo JA; Odewale G
    J Immunoassay Immunochem; 2016; 37(1):29-42. PubMed ID: 25879258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia.
    Prasetyo AA; Dirgahayu P; Sari Y; Hudiyono H; Kageyama S
    J Infect Dev Ctries; 2013 Jun; 7(6):453-67. PubMed ID: 23771289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and epidemiological characteristics of blood-borne virus infections among recent immigrants in Spain.
    Toro C; Jiménez V; Rodríguez C; Del Romero J; Rodés B; Holguín A; Alvarez P; García-Campello M; Gómez-Hernando C; Guelar A; Sheldon J; de Mendoza C; Simón A; Soriano V
    J Med Virol; 2006 Dec; 78(12):1599-608. PubMed ID: 17063510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.